If you have been reading about 反相色谱 and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Updated 2026-04-21. Numbers and descriptions here follow the published literature rather than marketing material.
Reported outcomes in large trials include dose-dependent weight reduction and improvements in glycemic markers over periods ranging from several months to more than a year. Whether the compound alters long-term cardiovascular or renal outcomes is being examined in dedicated outcome studies, so those questions remain open. Labeling describes gastrointestinal effects such as nausea and diarrhea, which tend to appear during dose escalation. Discontinuation rates and the durability of effects after treatment stops vary across study populations and are still debated.
Tirzepatide is a synthetic peptide developed as a dual agonist at the glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptors. Its structure is built on a GIP-derived backbone with non-natural amino acid substitutions and a fatty diacid side chain that promotes albumin binding and slows clearance. That modification supports once-weekly subcutaneous dosing. Registrational trial programs reported reductions in body weight and glycated hemoglobin alongside the drug's glycemic effects.
The peptide activates two G protein-coupled receptors, GIPR and GLP-1R. Binding triggers adenylyl cyclase activity and raises intracellular cyclic AMP in pancreatic beta cells, which potentiates insulin release when glucose is elevated. Signaling in the central nervous system is associated with reduced appetite and lower energy intake, while effects on gastric emptying and glucagon secretion are also reported. Because activity at both receptors is retained, the pharmacological profile is often described as incretin-based rather than selective for a single receptor.
After subcutaneous injection, absorption is gradual, and peak plasma levels are generally reached within one to three days. Albumin binding extends the apparent half-life to roughly five days, which supports a weekly administration schedule. Metabolism proceeds mainly through proteolytic cleavage of the peptide backbone and beta-oxidation of the fatty acid chain, rather than through cytochrome P450 pathways. Eliminated fragments are largely recycled through general protein turnover, and excretion of intact drug in urine is minimal. These properties distinguish the molecule from short-acting incretin mimetics.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic 39-residue peptide | GIP-derived backbone with non-natural residues |
| Molar mass | Approximately 4.8 kDa | Peptide chain plus linker and lipid modifications |
| Appearance | White to off-white powder | Typical of lyophilized research material |
| Solubility | Soluble in water and aqueous buffer | Practically insoluble in nonpolar solvents |
| Storage temperature | Typically −20 °C for dry powder | Solutions usually held at 2–8 °C short term |
Research and analytical settings increasingly require documentation of peptide origin and chain of custody. Certificate of analysis documents typically report purity by chromatographic area, mass confirmation, appearance, and residual solvent or counterion content. Independent verification by an accredited laboratory is common when a material will be used in a regulated study. Open questions remain about how well compendial methods transfer between laboratories, and about which impurity thresholds are meaningful for materials not intended for clinical use.
Peptide-based pharmaceutical products such as tirzepatide require controlled temperature management to preserve structural integrity. Manufacturer labeling generally specifies refrigeration at 2 to 8 degrees Celsius before first use, with protection from light and freezing. Exposure to repeated temperature cycling can promote aggregation or deamidation, which alters the analytical profile even when the visible solution appears unchanged. Once a product is in use, the permitted storage window and temperature range are defined by the specific labeled presentation rather than by general peptide rules.
Published work supports the view that engaging two incretin receptors produces changes in glucose handling and body weight larger than those seen with single-receptor activation. Why that difference arises is not fully settled. Open questions include how much of the observed weight effect depends on central versus peripheral signaling, and whether the two receptors form interacting complexes. Most reported findings come from controlled trials and animal models, and translation between species is imperfect. Further research is expected to refine these points over time.
Tirzepatide is a synthetic peptide built from 39 amino acid residues. Its sequence is related to human glucose-dependent insulinotropic polypeptide, with modifications that include a C-terminal extension and a C20 fatty diacid joined through a linker. Those changes raise the molecule's affinity for serum albumin, which slows renal filtration and lengthens the time it stays in circulation. The free base has an average molecular mass near 4813.5 daltons. The compound is made by solid-phase peptide synthesis followed by chromatographic purification.
质量控制环节关注外观、含量、纯度、有关物质、水分与微生物限度等项目。检测结果需要有对照品和系统适用性数据支持，单次测定不足以判定批次的稳定性。实验室之间方法转移时，色谱柱品牌与梯度差异常导致保留时间漂移，因此方法验证十分必要。
固体状态的 tirzepatide 通常以冻干粉形式保存，推荐在低温、避光、干燥条件下存放，常见区间为 2 至 8 摄氏度，长期保存可考虑更低温度并避免反复冻融。冻融循环会导致肽链聚集或析出，从而影响后续定量结果。容器密封性与湿度控制同样是稳定性研究中反复强调的因素。
溶解操作一般使用注射用水或适宜的水性缓冲液，必要时加入少量助溶剂以改善溶解速度，但应避免剧烈涡旋振荡，因为剪切力可能促进聚集。配制后的溶液在冷藏条件下的稳定时间通常短于固体形态，具体时限取决于浓度、缓冲体系与容器材质。是否加入防腐成分，则取决于用途是否为多次取样。
Receptor activation by tirzepatide raises intracellular cyclic AMP through Gs-coupled signalling at both targets. At the GLP-1 receptor the downstream effect includes glucose-dependent insulin release, suppressed glucagon secretion, delayed gastric emptying, and reduced appetite signalling in the hypothalamus. GIP receptor engagement adds insulinotropic activity and appears to influence lipid handling in adipose tissue. Because both receptors are stimulated at the same time, the pharmacological profile differs from that of selective GLP-1 receptor agonists, and the relative contribution of each arm remains an area of active investigation.
Clinical development proceeded through large phase 3 programmes in type 2 diabetes and in obesity or overweight with at least one weight-related comorbidity. Regulatory approvals followed in several jurisdictions for both indications. Weekly subcutaneous dosing reflects an elimination half-life of roughly five days. Open questions include the durability of metabolic effects after treatment stops, long-term cardiovascular and hepatic outcomes beyond completed trials, and whether the dual mechanism confers benefits independent of total receptor occupancy. Published literature continues to expand on these points. Substantial uncertainty remains about interindividual variability in response.
Tirzepatide is a synthetic linear peptide of 39 amino acids that acts as a dual agonist at the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. Its sequence derives from native GIP but incorporates non-natural residues and a C20 fatty diacid moiety linked to a lysine side chain. The lipophilic chain promotes albumin binding, which slows renal clearance and extends circulation time. The unmodified peptide has a molecular formula of C225H348N48O68 and a molecular mass near 4,813 daltons.
{\displaystyle \varepsilon _{\rm {a}}(f)\approx \sum _{i=1}^{N}\left|{\frac {\partial f}{\partial x_{i}}}\right|\varepsilon _{\rm {a}}(x_{i})=\left|{\frac {\partial f}{\partial x_{1}}}\right|\varepsilon _{\rm {a}}(x_{1})+\left|{\frac {\partial f}{\partial x_{2}}}\right|\varepsilon _{\rm {a}}(x_{2})+\ldots +\left|{\frac {\partial f}{\partial x_{N}}}\right|\varepsilon _{\rm {a}}(x_{N})}
=== Vitamin B12 === Spirulina contains no vitamin B12 naturally, and spirulina supplements are not considered a reliable source of vitamin B12, as they contain predominantly pseudovitamin B12 (Coα-[α-(7-adenyl)]-Coβ-cyanocobamide), which is biologically inactive in humans. In a 2009 position paper on vegetarian diets, the American Dietetic Association stated that spirulina is not a reliable source of active vitamin B12. The medical literature similarly advises that spirulina is unsuitable as a source of B12.
Full-fat soybean meal, made from whole soybeans. It has a high metabolizable energy concentration. (For example, metabolizable energy for swine in this product is about 3.69 megacalories (i.e. 15.4 MJ) per kg dry matter.) Crude protein concentration is about 38 percent (as fed). This kind of product is sometimes fed to various classes of livestock. Defatted soybean meal, containing no hulls. This product has an intermediate energy concentration. (For example, Balaji metabolizable energy for swine in this product is about 3.38 megacalories (i.e. 14.1 MJ) per kg dry matter.) Crude protein concentration is about 48 percent. This percentage [which is commonly used in describing the product] is calculated at the typical as-fed moisture content of 88 percent. Thus, crude protein concentration expressed on a dry matter basis is 54 percent. This product is commonly fed to swine, broilers and layers. Defatted soybean meal, containing soybean hulls. The hulls are readily digestible by ruminant livestock. This product is often fed as a protein supplement for domestic ruminants. Ruminant-metabolizable energy concentration is about 3.0 megacalories (i.e. about 12.5 MJ) per kg dry matter, and crude protein concentration is about 44 percent. The latter percentage [which is commonly used in describing the product] is calculated at the typical as-fed moisture content of 90 percent. Thus, crude protein concentration on a dry matter basis is 49 percent.
Noriega was educated first at the Escuela República de México, and later at the Instituto Nacional, a well-regarded high school in Panama City that had produced a number of nationalist political leaders. He was described as an "oddly serious child," a bookish student always neatly dressed by his godmother. During his time in the Instituto Nacional he met his older half-brother Luis Carlos Noriega Hurtado, a socialist activist and also a student at the school: Manuel had not previously met his siblings. Manuel began living with Luis, who introduced him to politics, including recruiting him into the Socialist Party's youth wing. Luis Noriega would later direct Panama's electoral tribunal. During his time in the socialist youth group, Noriega took part in protests and authored articles criticizing the U.S. presence in Panama. He is reported to have begun his association with the U.S. intelligence services at this time, providing information about the activities of his comrades. A$10.70 payment in 1955 was the first he received from the U.S. Noriega intended to become a doctor, but was unable to secure a place in the University of Panama's medical school. After graduating from the Instituto Nacional, Noriega won a scholarship to Chorrillos Military School in the Peruvian capital of Lima, with the help of Luis, who had by then received a position in the Panamanian embassy in Peru. Noriega began studying in Lima in 1958. While there, he made the acquaintance of Roberto Díaz Herrera, then studying at the Peruvian Police academy, who later became a close ally.
Sources: en.wikipedia.org
The Marvel Cinematic Universe (MCU) is an American media franchise and shared universe centered on a series of superhero films produced by Marvel Studios, based on characters from American comic books published by Marvel Comics. The franchise is owned by the Walt Disney Company and includes television series, short films, digital series, and literature. The shared universe, much like the original Marvel Universe in comic books, was established by crossing over common plot elements, settings, cast, and characters. Marvel Studios releases its films in groups called "Phases", with the first three phases collectively known as "The Infinity Saga" and the following three phases as "The Multiverse Saga". The first MCU film, Iron Man (2008), began Phase One, which culminated in the crossover film The Avengers (2012). Phase Two began with Iron Man 3 (2013) and concluded with Ant-Man (2015), while Phase Three began with Captain America: Civil War (2016) and concluded with Spider-Man: Far From Home (2019). Black Widow (2021) is the first film in Phase Four, which concluded with Black Panther: Wakanda Forever (2022), while Phase Five began with Ant-Man and the Wasp: Quantumania (2023) and concluded with Thunderbolts* (2025). Phase Six began with The Fantastic Four: First Steps (2025) and will conclude with Avengers: Secret Wars (2027). Marvel Television expanded the universe to television, first on network television with Agents of S.H.I.E.L.D. on ABC in 2013 before further expanding to streaming television on Netflix and Hulu and to cable television on Freeform.
==== Tolerance ==== Chronic use of benzodiazepines, such as chlordiazepoxide, leads to the development of tolerance, with a decrease in number of benzodiazepine binding sites in mice forebrains. The Committee of Review of Medicines, who carried out an extensive review of benzodiazepines including chlordiazepoxide, found—and were in agreement with the US Institute of Medicine and the conclusions of a study carried out by the White House Office of Drug Policy and the US National Institute on Drug Abuse—that there was little evidence that long-term use of benzodiazepines was beneficial in the treatment of insomnia due to the development of tolerance. Benzodiazepines tended to lose their sleep-promoting properties within 3 to 14 days of continuous use, and in the treatment of anxiety the committee found that there was little convincing evidence that benzodiazepines retained efficacy in the treatment of anxiety after four months' continuous use due to the development of tolerance.
===== Sweden ===== Cannabidiol is classified as a medical product in Sweden. However, in July 2019, Supreme Court of Sweden ruled that CBD oil with any concentration of THC falls under the narcotic control laws.
In 2014, the Equality Tribunal ruled in favor of Dr Micheline Sheehy Skeffington, granddaughter of the famous Irish feminist couple Hannah Sheehy Skeffington and Francis Sheehy Skeffington, who claimed she had been discriminated against on the grounds of gender during 2009. The university "unreservedly" accepted the decision that the "hiring process was flawed". In 2015 with "widespread concern" among staff, mandatory unconscious bias training was introduced for senior staff, including heads of school and interview boards. In 2017 Dr Elizabeth Tilley was deemed to have exceeded qualifications for senior lectureship following a Labour Court hearing and promoted. In 2017, the gender ratio of senior lecturers in the university was 60:40 in favour of men. The ratio of professorships, the most senior academic grade, was 87:13 in favor of men. In 2018 the university achieved bronze status in the Athena SWAN recognises a commitment to advancing gender equality in higher education and research careers. In 2018 a further four female lecturers who had also applied for promotion in 2009 were promoted having settled their cases "amicably". The university launched its Strategic Plan "Shared Vision, Shaped By Values" (for the period 2020–2025) in 2020. Also in 2020, the university was awarded €4 million from the EU's Horizon 2020 Research and Innovation programme to support its Solar2chem project. In April 2022, it was announced that NUI Galway would be renamed "Ollscoil na Gaillimhe – University of Galway" in summer 2022, amid confusion over its proper title.
Zn(s) + CuSO4(aq) → ZnSO4(aq) + Cu(s) In the above reaction, zinc metal displaces the copper(II) ion from the copper sulfate solution, thus liberating free copper metal. The reaction is spontaneous and releases 213 kJ per 65 g of zinc. The ionic equation for this reaction is:
Sources: en.wikipedia.org
It acts as an agonist at both the GIP and GLP-1 receptors, two related class B G protein-coupled receptors. This dual activity distinguishes it from single-receptor GLP-1 agonists. The clinical consequences of engaging both receptors are still being characterized.
It is given by subcutaneous injection, generally on a weekly schedule. Dosing usually begins low and increases in steps to limit gastrointestinal side effects. Formulated product is supplied as a ready-to-use pen or vial in most markets.
No. Receptor engagement is documented, but how central appetite circuits, gut signals, and insulinotropic effects combine is incompletely resolved. Investigators continue to separate GIP-driven from GLP-1-driven contributions in animal and human models.
It is a synthetic linear peptide that acts as a dual agonist at the GIP and GLP-1 receptors. It combines a modified incretin backbone with a fatty diacid side chain that extends its circulation time. It is not a small-molecule drug and is not orally absorbed in its native form.